Us TOO in Seattle Prostate Cancer Support Group meetings are open to men with prostate cancer, their loved ones, friends, and caregivers. Our goal is to provide comprehensive information on prostate cancer, its diagnoses, treatments, side effects, current research and other aspects that may be used to help us make informed decisions about the disease. Us TOO in Seattle monthly meetings offer peer-to-peer interaction and support, plus unbiased information from experts in areas related to prostate cancer including surgery, radiation, medication, psychology, healthy lifestyles, and more.
Spouses, partners, other family members and caregivers are welcome.
Each Us TOO in Seattle meeting starts at 6pm with a facilitated discussion between participants followed by an educational presentation at 7pm by a healthcare provider or other speaker. Meetings end promptly at 8:00.Next Meeting
Wednesday, July 22, 2020, 6 -8 pm ONLINE
Roundtable discussion among members and guests, with input and commentary from Dr. Ed Weber, 6 pm to 8 pm.
Guest Speaker: Dr. Robert Meier, MD
Robert Meier MD is a Radiation Oncologist at Swedish Cancer Institute and the Medical Director of Swedish Radiosurgery Center in Seattle. His interest in cancer dates back to his college years, when his father was diagnosed with prostate cancer and cured by a radioactive seed implant. After receiving his Medical Doctorate from UCLA School of Medicine in Los Angeles, CA, he completed his residency training at UCLA Department of Radiation Oncology. Dr. Meier gained an appreciation for research and academic medicine as Clinical Assistant Professor at Stanford University Department of Radiation Oncology, while practicing at the Palo Alto Medical Foundation.
Dr. Meier moved his practice to Seattle to work with the pioneers of prostate brachytherapy at the Swedish Cancer Institute. After also gaining expertise in Gamma Knife radiosurgery, he cofounded the Swedish Radiosurgery Center. Recognizing that CyberKnife offered the advantages of brachytherapy with the potential for less toxicity, he began his pioneering work in prostate stereotactic body radiotherapy (SBRT). Dr. Meier wrote the benchmark protocol for doseescalated treatment, and is the Principle Investigator on the first national multi-institutional study of CyberKnife for prostate cancer.
Dr. Meier is an internationally recognized expert in stereotactic radiotherapy. He has lectured extensively and has published numerous articles on stereotactic radiotherapy and on SBRT for prostate cancer.
Wednesday, August 26, 2020: 6:00 p.m. Us TOO August meeting. Details coming.